Clinical trials are urgently needed for PSP and CBD. Dr. Maura Malpetti and her team at the University of Cambridge have identified chronic brain inflammation as a key contributor to disease progression, and are developing a blood test for inflammation that will help track the effectiveness of clinical trials and treatments, thus accelerating the development of more clinical trials. 

Dr. Malpetti spoke to us about the mysteries of brain inflammation, its role in PSP and CBD and how this research could revolutionize the way we diagnose, treat and understand these conditions. 

With support from CurePSP’s Pipeline grant program, which provides seed funding to support translational projects focusing on new therapeutics and biomarkers for tauopathies, Dr. Malpetti will be developing an innovative blood test to measure patterns of inflammation in people living with PSP and CBD. Read more about her study here.